A feasibility study of EdoXaban for the Cancer-Associated asymptomatic Venous thromboEmbolism in Japanese gastrointestinal cancer patients receiving chemotherapy. (ExCAVE study)

Trial Profile

A feasibility study of EdoXaban for the Cancer-Associated asymptomatic Venous thromboEmbolism in Japanese gastrointestinal cancer patients receiving chemotherapy. (ExCAVE study)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms ExCAVE study
  • Most Recent Events

    • 17 Feb 2018 Status changed from not yet recruiting to recruiting.
    • 24 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top